This past week Visikol participated in Boston Biotech Week and Dr. Michael Johnson pitched during the biotech startup competition and came in second place overall out of twenty companies.
The competition brought out companies from around-the-world and was judged by Investors and Business Development Directors from Abbvie, Atlas Venture, Agent Capital, SR One, MRL Venture Fund and Lightstone Ventures.
